<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VDI</journal-id>
<journal-id journal-id-type="hwp">spvdi</journal-id>
<journal-title>Journal of Veterinary Diagnostic Investigation</journal-title>
<issn pub-type="ppub">1040-6387</issn>
<issn pub-type="epub">XXXX-XXXX</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1040638712442931</article-id>
<article-id pub-id-type="publisher-id">10.1177_1040638712442931</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chimeric protein A/G conjugate for detection of anti–<italic>Toxoplasma gondii</italic> immunoglobulin G in multiple animal species</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Schaefer</surname><given-names>John J.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>White</surname><given-names>Holly A.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Schaaf</surname><given-names>Stephanie L.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Mohammed</surname><given-names>Hussni O.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Wade</surname><given-names>Susan E.</given-names></name>
<xref ref-type="corresp" rid="corresp1-1040638712442931">1</xref>
</contrib>
<aff id="aff1-1040638712442931">Department of Population Medicine and Diagnostic Sciences, Cornell University School of Veterinary Medicine, Ithaca, NY</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1040638712442931"><label>1</label>Susan E. Wade, Animal Health Diagnostic Center, Farrier Road, Cornell University, Ithaca, NY 14853. <email>sew9@cornell.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>24</volume>
<issue>3</issue>
<fpage>572</fpage>
<lpage>575</lpage>
<permissions>
<copyright-statement>© 2012 The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American Association of Veterinary Laboratory Diagnosticians</copyright-holder>
</permissions>
<abstract>
<p>Serological testing for toxoplasmosis diagnosis remains the method of choice in human medicine due to the accessibility of the requisite sample, the difficulty in predicting the parasite’s location in the host for direct detection, and the availability of established commercial methods. In veterinary medicine, although the first 2 conditions are unchanged, there is a need for commercially produced test methods that are validated for <italic>Toxoplasma gondii</italic> detection across the range of animal species that can serve as intermediate hosts. The development of such a serological method for animals would allow the diagnosis of toxoplasmosis in individual animals and a higher throughput method for population-level toxoplasmosis surveys. The incorporation of a non–species-specific chimeric protein A/G conjugate into an anti–<italic>Toxoplasma</italic> immunoglobulin G enzyme-linked immunosorbent assay is described. Serum from potential intermediate hosts was reevaluated using this method and compared with earlier testing using an established agglutination procedure. Very good agreement between the 2 tests was noted (κ = 0.81), establishing the method as a useful option for veterinary diagnostic testing.</p>
</abstract>
<kwd-group>
<kwd>Enzyme-linked immunosorbent assay</kwd>
<kwd>protein A/G</kwd>
<kwd><italic>Toxoplasma gondii</italic></kwd>
<kwd>toxoplasmosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Toxoplasmosis, caused by <italic>Toxoplasma gondii</italic>, is a disease that has health and economic impacts across a broad spectrum of animal species.<sup><xref ref-type="bibr" rid="bibr8-1040638712442931">8</xref>,<xref ref-type="bibr" rid="bibr14-1040638712442931">14</xref>,<xref ref-type="bibr" rid="bibr15-1040638712442931">15</xref></sup> Diagnosis of toxoplasmosis is complicated both by the nonspecific nature of clinical signs and the complexity of the pathogen’s life cycle, making direct detection unfeasible in most situations.<sup><xref ref-type="bibr" rid="bibr5-1040638712442931">5</xref>-<xref ref-type="bibr" rid="bibr7-1040638712442931">7</xref>,<xref ref-type="bibr" rid="bibr9-1040638712442931">9</xref>,<xref ref-type="bibr" rid="bibr11-1040638712442931">11</xref>,<xref ref-type="bibr" rid="bibr20-1040638712442931">20</xref></sup> A range of serological options have been developed to detect exposure to <italic>Toxoplasma</italic> in human beings, some of which have utility in veterinary diagnostics.<sup><xref ref-type="bibr" rid="bibr17-1040638712442931">17</xref>,<xref ref-type="bibr" rid="bibr18-1040638712442931">18</xref></sup> Various permutations of agglutination testing can be applied successfully to testing a wide range of animal species, as they have no species-specific conjugate requirement.<sup><xref ref-type="bibr" rid="bibr3-1040638712442931">3</xref>,<xref ref-type="bibr" rid="bibr4-1040638712442931">4</xref>,<xref ref-type="bibr" rid="bibr13-1040638712442931">13</xref></sup> However, there are no commercially produced agglutination tests currently available in the United States, whereas many other serological tests are either available or being developed for human testing.<sup><xref ref-type="bibr" rid="bibr18-1040638712442931">18</xref></sup> Unfortunately, many of these tests require protein conjugate for the detection of anti-<italic>Toxoplasma</italic> antibody in the serum of interest. Most of the protein conjugates available are only effective in binding to antibody from specific animal species. The description of the use of protein conjugates that bind to the immunoglobulin (Ig)G of many different animal species is a promising new platform for serological test development.<sup><xref ref-type="bibr" rid="bibr19-1040638712442931">19</xref>,<xref ref-type="bibr" rid="bibr22-1040638712442931">22</xref>,<xref ref-type="bibr" rid="bibr25-1040638712442931">25</xref></sup></p>
<p>The use of non–species-specific protein conjugates A and G allows the testing of sera from most of the veterinary species of interest on an enzyme-linked immunosorbent assay (ELISA) platform. However, this requires 2 parallel tests to be run with 2 sets of control, one for samples to be tested with protein A conjugate and one for those to be tested with protein G. The development of chimeric protein A/G conjugate from staphylococcal protein A and streptococcal protein G has been described.<sup><xref ref-type="bibr" rid="bibr10-1040638712442931">10</xref></sup> This chimeric protein A/G conjugate allows the testing of all species formerly tested by the 2 proteins individually with a single conjugate, thereby simplifying the procedure and making it more attractive as a potential substitute for currently used agglutination techniques.<sup><xref ref-type="bibr" rid="bibr1-1040638712442931">1</xref>,<xref ref-type="bibr" rid="bibr25-1040638712442931">25</xref></sup> A single test allows higher throughput and is better suited to commercial development and automation. In the current study, the results of a commercially produced indirect hemagglutination assay were compared with those of a commercially available IgG ELISA, modified to detect IgG antibody in multiple animal species by the substitution of protein A/G horseradish peroxidase conjugate for the kit-provided antihuman conjugate.</p>
<p>Blood samples were collected in clot tubes from animals by referring veterinarians. The extracted serum samples were submitted to the Animal Health Diagnostic Center at Cornell University (Ithaca, New York) from 2002 to 2008 for detection of <italic>Toxoplasma</italic> exposure by indirect hemagglutination. After storage at 5°C, positive samples with a sufficient amount of serum remaining and a sampling of negative samples were reassessed using the modified IgG ELISA technique in 2011. The sera tested included samples from 14 alpacas, 17 sheep, 17 goats, 15 horses, and 56 dogs.</p>
<p>Seroreactivity to <italic>Toxoplasma</italic> antigens was initially evaluated using an indirect hemagglutination assay (IHA).<sup><xref ref-type="fn" rid="fn1-1040638712442931">a</xref></sup> The commercial preparation of the IHA had perfect qualitative agreement with the Centers for Disease Control and Prevention <italic>Toxoplasma</italic> indirect fluorescent antibody test in their evaluation of human serum samples.<sup><xref ref-type="bibr" rid="bibr24-1040638712442931">24</xref></sup> Serum containing anti-<italic>Toxoplasma</italic> antibody causes agglutination of the sheep red blood cells coated with antigen as part of the test procedure.<sup><xref ref-type="bibr" rid="bibr3-1040638712442931">3</xref>,<xref ref-type="bibr" rid="bibr13-1040638712442931">13</xref></sup> Nonspecific agglutination is detected by assaying coated and noncoated red blood cells in separate wells. Interpretation is based on observation of presence or absence of a red blood cell mat covering the bottom of the test well on completion of incubation. The test is equally effective for human and animal diagnostic work because no species-specific conjugate is required for antibody detection.<sup><xref ref-type="bibr" rid="bibr23-1040638712442931">23</xref></sup> The procedure was used as a reference test to evaluate the performance of the modified IgG ELISA, with details described in an earlier study.<sup><xref ref-type="bibr" rid="bibr19-1040638712442931">19</xref></sup></p>
<p>A commercial IgG ELISA<sup><xref ref-type="fn" rid="fn2-1040638712442931">b</xref></sup> was modified by use of protein A/G horseradish peroxidase conjugate<sup><xref ref-type="fn" rid="fn3-1040638712442931">c</xref></sup> to replace the conjugated goat antihuman IgG included in the kit. Samples, controls, and a calibrator were evaluated after dilution of 1:21 with kit-supplied diluent (containing Tween-20, bovine serum albumin, and phosphate buffered saline). These components were added to kit wells that had been sensitized by passive absorption with <italic>Toxoplasma</italic> antigen. Any antigen-specific antibody contained in the sample binds to the immobilized antigen. Protein A/G conjugate was added to each well to attach to any immobilized IgG antibody. Following washing, microwells were incubated with tetramethylbenzidine, a peroxidase substrate solution that changes color when hydrolyzed by the presence of peroxidase. Color intensity of the sample indicated antibody concentration in the microwell. This was evaluated using a microplate reader with light at a wavelength of 450 nm. Comparison to kit-provided calibrators guided the identification of positive versus negative serum, with a ratio of sample color intensity to kit calibrator color intensity of greater than or equal to 1.1 indicating a positive reaction for anti–<italic>Toxoplasma</italic> IgG antibody as described by the kit insert. A ratio between 0.9 and 1.1 (noninclusive) was considered an indeterminate result, and less than or equal to 0.9 was considered a negative result.</p>
<p>Protein A/G chimeric horseradish peroxidase conjugate was used in the IgG ELISA assays instead of the kit conjugate to allow testing of multiple animal species. This protein is produced by gene fusion of the Fc-binding domains of protein A and protein G, bacterial cell wall proteins with affinity for IgG in a range of species. It contains 4 Fc-binding domains from protein A and 2 from protein G, providing binding for all antibody species and subclasses recognized by either protein A or protein G.<sup><xref ref-type="bibr" rid="bibr10-1040638712442931">10</xref></sup> Protein A conjugate is reported to provide strong binding to IgG antibody of mice, rabbits, cats, dogs, and pigs, whereas protein G conjugate is reported to provide strong binding to IgG antibody of mice, guinea pigs, rabbits, cows, sheep, goats, alpacas, horses, and pigs.<sup><xref ref-type="bibr" rid="bibr2-1040638712442931">2</xref>,<xref ref-type="bibr" rid="bibr19-1040638712442931">19</xref>,<xref ref-type="bibr" rid="bibr21-1040638712442931">21</xref></sup> Protein was received as lyophilized powder and was diluted 1:40,000 with phosphate buffered saline (pH 7.2) prior to use. The dilution was determined by testing against kit controls to satisfy quality control parameters.</p>
<p>The significance of association between the results of the IHA and the ELISA was evaluated using the McNemar chi-square test.<sup><xref ref-type="bibr" rid="bibr16-1040638712442931">16</xref></sup> The degree of agreement between the results from the 2 tests was quantified using kappa statistics. The accuracy of the ELISA test in detecting exposure to <italic>Toxoplasma</italic> was evaluated in comparison to the IHA and measured using the relative sensitivity and specificity. The expected performance of the ELISA at different cutoff points was examined using the receiver operating characteristic (ROC) curve.<sup><xref ref-type="bibr" rid="bibr12-1040638712442931">12</xref></sup></p>
<p>Serum samples were evaluated from multiple animal species using both the IHA and the IgG ELISA modified as described. The sera tested included samples from some of the more commonly tested intermediate hosts for the parasite. There was no significant difference detected between positive versus negative results when comparing IHA and ELISA results with McNemar chi-square (<italic>P</italic> = 1.0), with a kappa value of agreement of 0.81 (95% confidence interval [CI]: 0.71–0.92 calculated using GraphPad<sup><xref ref-type="fn" rid="fn4-1040638712442931">d</xref></sup>), as noted in <xref ref-type="table" rid="table1-1040638712442931">Table 1</xref>. This reaffirms the finding of an earlier study, using protein A and G conjugates individually, of very good agreement between the agglutination and ELISA testing. The breakdown of these results by animal species is provided in <xref ref-type="table" rid="table2-1040638712442931">Table 2</xref>, with all species, except horses, demonstrating very good to perfect agreement between the 2 test methods. The relative sensitivity of this ELISA using chimeric protein A/G conjugate was found to be 92% (95% CI: 82–97%) and relative specificity 89% (95% CI: 77–96% calculated using VassarStats<sup><xref ref-type="fn" rid="fn5-1040638712442931">e</xref></sup>) when the IHA results were used as a gold standard and when positive versus negative ELISA results were determined using the manufacturer’s guidelines,<sup><xref ref-type="fn" rid="fn2-1040638712442931">b</xref></sup> including 0.9–1.1 as the equivocal range for optical density ratios. The variation of relative sensitivity and specificity at different optical density ratios is shown in <xref ref-type="fig" rid="fig1-1040638712442931">Figure 1</xref>. The associated ROC curve is depicted in <xref ref-type="fig" rid="fig2-1040638712442931">Figure 2</xref>.</p>
<table-wrap id="table1-1040638712442931" position="float">
<label>Table 1.</label>
<caption>
<p>Comparison of indirect hemagglutination assay (IHA) to the modified immunoglobulin G enzyme-linked immunosorbent assay (ELISA).</p>
</caption>
<graphic alternate-form-of="table1-1040638712442931" xlink:href="10.1177_1040638712442931-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">ELISA+</th>
<th align="center">ELISA–</th>
<th align="center">Total</th>
</tr>
</thead>
<tbody>
<tr>
<td>IHA+</td>
<td>58</td>
<td>5</td>
<td>63</td>
</tr>
<tr>
<td>IHA–</td>
<td>6</td>
<td>50</td>
<td>56</td>
</tr>
<tr>
<td>Total</td>
<td>64</td>
<td>55</td>
<td>119</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table2-1040638712442931" position="float">
<label>Table 2.</label>
<caption>
<p>Results of modified immunoglobulin G enzyme-linked immunosorbent assay testing by species.</p>
</caption>
<graphic alternate-form-of="table2-1040638712442931" xlink:href="10.1177_1040638712442931-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Species</th>
<th align="center">Samples tested</th>
<th align="center">True positive</th>
<th align="center">False positive</th>
<th align="center">False negative</th>
<th align="center">True negative</th>
<th align="center">Kappa value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alpaca</td>
<td>14</td>
<td>8</td>
<td>1</td>
<td>0</td>
<td>5</td>
<td>0.85</td>
</tr>
<tr>
<td>Sheep</td>
<td>17</td>
<td>10</td>
<td>0</td>
<td>0</td>
<td>7</td>
<td>1.0</td>
</tr>
<tr>
<td>Goat</td>
<td>17</td>
<td>11</td>
<td>0</td>
<td>0</td>
<td>6</td>
<td>1.0</td>
</tr>
<tr>
<td>Horse</td>
<td>15</td>
<td>2</td>
<td>1</td>
<td>4</td>
<td>8</td>
<td>0.24</td>
</tr>
<tr>
<td>Dog</td>
<td>56</td>
<td>27</td>
<td>4</td>
<td>1</td>
<td>24</td>
<td>0.82</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="fig1-1040638712442931" position="float">
<label>Figure 1.</label>
<caption>
<p>Variation in sensitivity and specificity relative to enzyme-linked immunosorbent assay optical density (OD) ratios.</p>
</caption>
<graphic xlink:href="10.1177_1040638712442931-fig1.tif"/></fig>
<fig id="fig2-1040638712442931" position="float">
<label>Figure 2.</label>
<caption>
<p>Receiver operating characteristic calculation for modified immunoglobulin G enzyme-linked immunosorbent assay.</p>
</caption>
<graphic xlink:href="10.1177_1040638712442931-fig2.tif"/></fig>
<p>The use of chimeric protein A/G conjugate has previously been demonstrated to be an effective means of serological testing in domestic animals.<sup><xref ref-type="bibr" rid="bibr1-1040638712442931">1</xref></sup> An earlier study explored its use for diagnostic testing in goats, dogs, cats, and pigs using an ELISA method developed in the researchers’ laboratory.<sup><xref ref-type="bibr" rid="bibr25-1040638712442931">25</xref></sup> In the current study, a commercially produced IgG ELISA kit for the diagnosis of <italic>Toxoplasma</italic> in human beings was modified to broaden the application of the test to domestic animals that can act as intermediate hosts of the parasite, having the benefit of being easily available to veterinary diagnosticians. Across the species tested, the modified kit produced a relative sensitivity of 92% and specificity of 89% using kit standards for determination of positive, equivocal and negative tests when the IHA was used as a gold standard. At the current time, no commercially available tests in the United States for the diagnosis of toxoplasmosis can be used across the broad spectrum of affected animal species. The current project demonstrates that a human ELISA kit can be modified with the replacement of a non–species-specific protein conjugate for the supplied antihuman IgG protein conjugate and produce very good results for some of the more commonly tested animal species. Non–species-specific protein conjugates, such as protein A/G, have great utility in developing new veterinary diagnostic testing methods for zoonotic diseases in which there are only medical diagnostic methods available.</p>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-1040638712442931">
<label>a.</label>
<p>Toxoplasmosis TPM-Test indirect hemagglutination kit, Wampole Laboratories, Princeton, NJ.</p>
</fn>
<fn fn-type="other" id="fn2-1040638712442931">
<label>b.</label>
<p>Toxo IgG II ELISA kit, Wampole Laboratories, Princeton, NJ.</p>
</fn>
<fn fn-type="other" id="fn3-1040638712442931">
<label>c.</label>
<p>Recombinant protein A/G horseradish peroxidase conjugate, Thermo Fisher Scientific, Waltham, MA.</p>
</fn>
<fn fn-type="other" id="fn4-1040638712442931">
<label>d.</label>
<p>GraphPad Software Inc., La Jolla, CA.</p>
</fn>
<fn fn-type="other" id="fn5-1040638712442931">
<label>e.</label>
<p>VassarStats: Website for Statistical Computation (<ext-link ext-link-type="uri" xlink:href="http://faculty.vassar.edu/lowry/VassarStats.html">faculty.vassar.edu/lowry/VassarStats.html</ext-link>).</p>
</fn>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>This research was made possible by the U.S. Department of Agriculture federal formula fund grant (NYC-478430).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1040638712442931">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhide</surname><given-names>MR</given-names></name>
<name><surname>Curlik</surname><given-names>J</given-names></name>
<name><surname>Travnicek</surname><given-names>M</given-names></name>
<name><surname>Lazar</surname><given-names>P</given-names></name>
</person-group>: <year>2004</year>, <article-title>Protein A/G dependent ELISA a promising diagnostic tool in Lyme disease seroprevalence in game animals and hunting dogs</article-title>. <source>Comp Immunol Microbiol Infect Dis</source> <volume>27</volume>:<fpage>191</fpage>–<lpage>199</lpage>.</citation>
</ref>
<ref id="bibr2-1040638712442931">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Björck</surname><given-names>L</given-names></name>
<name><surname>Kronvall</surname><given-names>G</given-names></name>
</person-group>: <year>1984</year>, <article-title>Purification and some properties of streptococcal protein G, a novel IgG-binding reagent</article-title>. <source>J Immunol</source> <volume>133</volume>:<fpage>969</fpage>–<lpage>974</lpage>.</citation>
</ref>
<ref id="bibr3-1040638712442931">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chordi</surname><given-names>A</given-names></name>
<name><surname>Walls</surname><given-names>KW</given-names></name>
<name><surname>Kagan</surname><given-names>IG</given-names></name>
</person-group>: <year>1964</year>, <article-title>Studies on the specificity of the indirect hemagglutination test for toxoplasmosis</article-title>. <source>J Immunol</source> <volume>93</volume>:<fpage>1024</fpage>–<lpage>1033</lpage>.</citation>
</ref>
<ref id="bibr4-1040638712442931">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Desmonts</surname><given-names>G</given-names></name>
<name><surname>Remington</surname><given-names>JS</given-names></name>
</person-group>: <year>1980</year>, <article-title>Direct agglutination test for diagnosis of <italic>Toxoplasma</italic> infection: method for increasing sensitivity and specificity</article-title>. <source>J Clin Microbiol</source> <volume>11</volume>:<fpage>562</fpage>–<lpage>568</lpage>.</citation>
</ref>
<ref id="bibr5-1040638712442931">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>JP</given-names></name>
</person-group>: <year>1995</year>, <article-title>Duration of immunity to shedding of <italic>Toxoplasma gondii</italic> oocysts by cats</article-title>. <source>J Parasitol</source> <volume>81</volume>:<fpage>410</fpage>–<lpage>415</lpage>.</citation>
</ref>
<ref id="bibr6-1040638712442931">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>JP</given-names></name>
</person-group>: <year>2004</year>, <article-title>Toxoplasmosis—a waterborne zoonosis</article-title>. <source>Vet Parasitol</source> <volume>126</volume>:<fpage>57</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr7-1040638712442931">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>JP</given-names></name>
<name><surname>Christie</surname><given-names>E</given-names></name>
<name><surname>Pappas</surname><given-names>PW</given-names></name>
</person-group>: <year>1977</year>, <article-title>Characterization of <italic>Toxoplasma gondii</italic> from the feces of naturally infected cats</article-title>. <source>J Infect Dis</source> <volume>136</volume>:<fpage>432</fpage>–<lpage>435</lpage>.</citation>
</ref>
<ref id="bibr8-1040638712442931">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>JP</given-names></name>
<name><surname>Jones</surname><given-names>JL</given-names></name>
</person-group>: <year>2008</year>, <article-title><italic>Toxoplasma gondii</italic> infection in humans and animals in the United States</article-title>. <source>Int J Parasitol</source> <volume>38</volume>:<fpage>1257</fpage>–<lpage>1278</lpage>.</citation>
</ref>
<ref id="bibr9-1040638712442931">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>JP</given-names></name>
<name><surname>Lindsay</surname><given-names>DS</given-names></name>
<name><surname>Speer</surname><given-names>CA</given-names></name>
</person-group>: <year>1998</year>, <article-title>Structures of <italic>Toxoplasma gondii</italic> tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts</article-title>. <source>Clin Microbiol Rev</source> <volume>11</volume>:<fpage>267</fpage>–<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr10-1040638712442931">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eliasson</surname><given-names>M</given-names></name>
<name><surname>Olsson</surname><given-names>A</given-names></name>
<name><surname>Palmcrantz</surname><given-names>E</given-names></name><etal/>
</person-group>.: <year>1988</year>, <article-title>Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G</article-title>. <source>J Biol Chem</source> <volume>263</volume>:<fpage>4323</fpage>–<lpage>4327</lpage>.</citation>
</ref>
<ref id="bibr11-1040638712442931">
<label>11.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Ferguson</surname><given-names>DJP</given-names></name>
<name><surname>Dubremetz</surname><given-names>JF</given-names></name>
</person-group>: <year>2007</year>, <article-title>The ultrastructure of</article-title> <source>Toxoplasma gondii</source>. <italic>In</italic>: <source><italic>Toxoplasma gondii</italic>—the model apicomplexan: perspectives and methods</source>, ed. <person-group person-group-type="editor">
<name><surname>Weiss</surname><given-names>LM</given-names></name>
<name><surname>Kim</surname><given-names>K</given-names></name>
</person-group>, pp. <fpage>19</fpage>–<lpage>46</lpage>. <publisher-name>Academic Press/Elsevier</publisher-name>, <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr12-1040638712442931">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greiner</surname><given-names>M</given-names></name>
<name><surname>Pfeiffer</surname><given-names>D</given-names></name>
<name><surname>Smith</surname><given-names>RD</given-names></name>
</person-group>: <year>2000</year>, <article-title>Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests</article-title>. <source>Prev Vet Med</source> <volume>45</volume>:<fpage>23</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr13-1040638712442931">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobs</surname><given-names>L</given-names></name>
<name><surname>Lunde</surname><given-names>MN</given-names></name>
</person-group>: <year>1957</year>, <article-title>A hemagglutination test for toxoplasmosis</article-title>. <source>J Parasitol</source> <volume>43</volume>:<fpage>308</fpage>–<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr14-1040638712442931">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kijlstra</surname><given-names>A</given-names></name>
<name><surname>Meerburg</surname><given-names>BG</given-names></name>
<name><surname>Mul</surname><given-names>MF</given-names></name>
</person-group>: <year>2004</year>, <article-title>Animal-friendly production systems may cause re-emergence of <italic>Toxoplasma gondii</italic></article-title>. <source>NJAS</source> <volume>52</volume>:<fpage>119</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr15-1040638712442931">
<label>15.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lindsay</surname><given-names>DS</given-names></name>
<name><surname>Dubey</surname><given-names>JP</given-names></name>
</person-group>: <year>2007</year>, <article-title>Toxoplasmosis in wild and domestic animals</article-title>. <italic>In</italic>: <source><italic>Toxoplasma gondii</italic>—the model apicomplexan: perspectives and methods</source>, ed. <person-group person-group-type="editor">
<name><surname>Weiss</surname><given-names>LM</given-names></name>
<name><surname>Kim</surname><given-names>K</given-names></name>
</person-group>, pp. <fpage>133</fpage>–<lpage>147</lpage>. <publisher-name>Academic Press/Elsevier</publisher-name>, <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr16-1040638712442931">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McNemar</surname><given-names>Q</given-names></name>
</person-group>: <year>1947</year>, <article-title>Note on the sampling error of the difference between correlated proportions or percentages</article-title>. <source>Psychometrika</source> <volume>12</volume>:<fpage>153</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr17-1040638712442931">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montoya</surname><given-names>JG</given-names></name>
<name><surname>Liesenfeld</surname><given-names>O</given-names></name>
</person-group>: <year>2004</year>, <article-title>Toxoplasmosis</article-title>. <source>Lancet</source> <volume>363</volume>:<fpage>1965</fpage>–<lpage>1976</lpage>.</citation>
</ref>
<ref id="bibr18-1040638712442931">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Remington</surname><given-names>JS</given-names></name>
<name><surname>Thulliez</surname><given-names>P</given-names></name>
<name><surname>Montoya</surname><given-names>JG</given-names></name>
</person-group>: <year>2004</year>, <article-title>Recent developments for diagnosis of toxoplasmosis</article-title>. <source>J Clin Microbiol</source> <volume>42</volume>:<fpage>941</fpage>–<lpage>945</lpage>.</citation>
</ref>
<ref id="bibr19-1040638712442931">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schaefer</surname><given-names>JJ</given-names></name>
<name><surname>White</surname><given-names>HA</given-names></name>
<name><surname>Schaaf</surname><given-names>SL</given-names></name><etal/>
</person-group>.: <year>2011</year>, <article-title>Modification of a commercial <italic>Toxoplasma gondii</italic> immunoglobulin G enzyme-linked immunosorbent assay for use in multiple animal species</article-title>. <source>J Vet Diagn Invest</source> <volume>23</volume>:<fpage>297</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr20-1040638712442931">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Speer</surname><given-names>CA</given-names></name>
<name><surname>Dubey</surname><given-names>JP</given-names></name>
</person-group>: <year>1998</year>, <article-title>Ultrastructure of early stages of infections in mice fed <italic>Toxoplasma gondii</italic> oocysts</article-title>. <source>Parasitology</source> <volume>116</volume>:<fpage>35</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr21-1040638712442931">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Surolia</surname><given-names>A</given-names></name>
<name><surname>Pain</surname><given-names>D</given-names></name>
<name><surname>Khan</surname><given-names>MI</given-names></name>
</person-group>: <year>1982</year>, <article-title>Protein A: nature’s universal anti-antibody</article-title>. <source>Trends Biochem Sci</source> <volume>7</volume>:<fpage>74</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr22-1040638712442931">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Werre</surname><given-names>SR</given-names></name>
<name><surname>Jacobson</surname><given-names>RH</given-names></name>
<name><surname>Bowman</surname><given-names>DD</given-names></name><etal/>
</person-group>.: <year>2002</year>, <article-title>Evaluation of kinetics and single-read enzyme-linked immunoassays for detection of <italic>Toxoplasma gondii</italic> antibodies in sheep</article-title>. <source>J Vet Diagn Invest</source> <volume>14</volume>:<fpage>225</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr23-1040638712442931">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>M</given-names></name>
<name><surname>McAuley</surname><given-names>JB</given-names></name>
</person-group>: <year>1991</year>, <article-title>Laboratory diagnosis of toxoplasmosis</article-title>. <source>Clin Lab Med</source> <volume>11</volume>:<fpage>923</fpage>–<lpage>939</lpage>.</citation>
</ref>
<ref id="bibr24-1040638712442931">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>M</given-names></name>
<name><surname>Ware</surname><given-names>DA</given-names></name>
<name><surname>Walls</surname><given-names>KW</given-names></name>
</person-group>: <year>1987</year>, <article-title>Evaluation of commercial serodiagnostic kits for toxoplasmosis</article-title>. <source>J Clin Microbiol</source> <volume>25</volume>:<fpage>2262</fpage>–<lpage>2265</lpage>.</citation>
</ref>
<ref id="bibr25-1040638712442931">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>D</given-names></name>
<name><surname>Wang</surname><given-names>Z</given-names></name>
<name><surname>Fang</surname><given-names>R</given-names></name><etal/>
</person-group>.: <year>2010</year>, <article-title>Use of protein AG in enzyme-linked immunosorbent assay for serodiagnosis of <italic>Toxoplasma gondii</italic> infection in four species of animals</article-title>. <source>Clin Vaccine Immunol</source> <volume>17</volume>:<fpage>485</fpage>–<lpage>486</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>